Truist Financial upgraded BioMarin Pharmaceutical to strong-buy, and Morgan Stanley lowered its target price on the company's stock.

The entities involved

• BioMarin Pharmaceutical →

  American company

  • Investors are comparing the financial performance metrics of BioMarin Pharmaceutical and Metagenomi.Sun 20:41
• Truist Financial →

  American bank holding company, formerly known as BB&T Corporation

  • MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.Mon 13:11
  • Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.Mon 11:04
• Morgan Stanley →

  U.S. investment bank

  • Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Mon 17:33
  • Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24

Related events

• Financial firms including Truist, Morgan Stanley, and Bank of America issued rating updates and price target changes on August 16, 2026.Aug 16
• Truist Financial dropped its price objective and set a buy rating, while Jefferies and Royal Bank of Canada also issued rating updates.Sep 14
• Truist Financial raised its target price on Teva Pharmaceutical Industries Ltd. stock.Aug 16
• MarketBeat aggregated analyst recommendations and price targets for BioMarin Pharmaceutical and Abeona Therapeutics Inc.Sep 4
• Truist Financial reissued a 'hold' rating and set a target price for Inspire Medical Systems.Aug 19